Secondary Trigeminal Neuralgia- Surgery vs. Radiosurgery: Wh
Trigeminal neuralgia (TN), is the most common form of severe facial pain. It may often be confused with other conditions. It has been described as one of the most painful conditions. The lifetime prevalence for TN is approximately 0.3%, and other facial pains are about 0.03%. TN is 15–20 times more common in persons with multiple sclerosis. While TN is often a straightforward diagnosis, opera good is essential, and not uncommonly, it may be confused with other conditions. A non-randomized, uncontrolled, unblinded study of 27 subjects evaluated the effect of BTxA over six months. A total of 88.9% had pain relief by more than 50% at the end of 6 months. About 50% required a second injection and 25% a third injection. Overall, BTxA offers an effective form of treatment for those individuals for whom oral medication such as oxcarbazepine has failed or for whom interventional therapies such as peripheral nerve ablations or microvascular decompression are not suitable. A study found that about 50% (range 36-65%) of the patients had complete relief of pain and were medication-free with stereotactic radiosurgery (SRS) and a lesser degree of pain control was reported in about 41% (range 29-52%) of the patients.

Source: https://www.neurologyindia.com/article.asp?issn=0028-3886;year=2022;volume=70;issue=3;spage=843;epage=844;aulast=Chandra
Like
Comment
Share